Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study

BackgroundRecent studies show that inflammatory processes may contribute to neuropathic pain. Cyclooxygenase-2 (Cox-2) is an inducible enzyme responsible for production of prostanoids, which may sensitise sensory neurones via the EP1 receptor. We have recently reported that while macrophages infiltrate injured nerves within days of injury, they express increased Cox-2-immunoreactivity (Cox-2-IR) from 2 to 3 weeks after injury. We have now investigated the time course of EP1 and Cox-2 changes in injured human nerves and dorsal root ganglia (DRG), and the chronic constriction nerve injury (CCI) model in the rat.MethodsTissue sections were immunostained with specific antibodies to EP1, Cox-2, CD68 (human macrophage marker) or OX42 (rat microglial marker), and neurofilaments (NF), prior to image analysis, from the following: human brachial plexus nerves (21 to 196 days post-injury), painful neuromas (9 days to 12 years post-injury), avulsion injured DRG, control nerves and DRG, and rat CCI model tissues. EP1 and NF-immunoreactive nerve fibres were quantified by image analysis.ResultsEP1:NF ratio was significantly increased in human brachial plexus nerve fibres, both proximal and distal to injury, in comparison with uninjured nerves. Sensory neurones in injured human DRG showed a significant acute increase of EP1-IR intensity. While there was a rapid increase in EP1-fibres and CD-68 positive macrophages, Cox-2 increase was apparent later, but was persistent in human painful neuromas for years. A similar time-course of changes was found in the rat CCI model with the above markers, both in the injured nerves and ipsilateral dorsal spinal cord.ConclusionDifferent stages of infiltration and activation of macrophages may be observed in the peripheral and central nervous system following peripheral nerve injury. EP1 receptor level increase in sensory neurones, and macrophage infiltration, appears to precede increased Cox-2 expression by macrophages. However, other methods for detecting Cox-2 levels and activity are required. EP1 antagonists may show therapeutic effects in acute and chronic neuropathic pain, in addition to inflammatory pain.

[1]  Yu-ping Jia,et al.  Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation , 2003, Pain.

[2]  J. Richards,et al.  Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. Induction in vivo and in vitro. , 1992, The Journal of biological chemistry.

[3]  K. Omote,et al.  The Effects of Peripheral Administration of a Novel Selective Antagonist for Prostaglandin E Receptor Subtype EP1, ONO-8711, in a Rat Model of Postoperative Pain , 2001, Anesthesia and analgesia.

[4]  S. Oldfield,et al.  Expression and regulation of prostaglandin E receptor subtype mRNAs in rat sensory ganglia and spinal cord in response to peripheral inflammation. , 2001, Prostaglandins & other lipid mediators.

[5]  K. Shimada,et al.  Cyclooxygenase-2 expression in Schwann cells and macrophages in the sciatic nerve after single spinal nerve injury in rats , 2004, Neuroscience Letters.

[6]  S. Narumiya,et al.  In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs , 1995, British journal of pharmacology.

[7]  R. Meyer,et al.  Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers , 2000, Pain.

[8]  C. Hoffmann.  COX-2 in brain and spinal cord implications for therapeutic use. , 2000, Current medicinal chemistry.

[9]  H. Schaible,et al.  Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. , 2001, Progress in neurobiology.

[10]  R. Myers,et al.  Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-α expression , 1998, Pain.

[11]  H. Schaible,et al.  Prostaglandins and cycloxygenases in the spinal cord , 2001, Progress in Neurobiology.

[12]  L. O. Randall,et al.  A method for measurement of analgesic activity on inflamed tissue. , 1957, Archives internationales de pharmacodynamie et de therapie.

[13]  M. Breckwoldt,et al.  PGE2 and PGF2α release by human peritoneal macrophages in endometriosis , 1996 .

[14]  L. Mendell,et al.  Neurotrophins and hyperalgesia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Saraste,et al.  FEBS Lett , 2000 .

[16]  P. Isakson,et al.  The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1 , 2001, The Journal of Neuroscience.

[17]  H. S. Kim,et al.  The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. , 2001, The Journal of clinical investigation.

[18]  H. Schaible,et al.  Changes in the Effect of Spinal Prostaglandin E 2 during Inflammation : Prostaglandin E ( EP 1 – EP 4 ) Receptors in Spinal Nociceptive Processing of Input from the Normal or Inflamed Knee Joint , 2004 .

[19]  K. Omote,et al.  Role of Prostaglandin Receptor EP1 in the Spinal Dorsal Horn in Carrageenan-induced Inflammatory Pain , 2002, Anesthesiology.

[20]  J. Humes,et al.  Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. , 1979, Prostaglandins.

[21]  C. Sommer,et al.  Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia , 2004, Neuroscience Letters.

[22]  O. Yuge,,et al.  Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model , 2004, Brain Research.

[23]  Linda R Watkins,et al.  Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. , 2002, Physiological reviews.

[24]  C. Woolf,et al.  Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. , 2002, Trends in molecular medicine.

[25]  S. Summerfield,et al.  The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization , 2005, Journal of Pharmacology and Experimental Therapeutics.

[26]  S. Narumiya,et al.  Function of prostanoid receptors: studies on knockout mice. , 2002, Prostaglandins & other lipid mediators.

[27]  A. Hobson,et al.  The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. , 2003, Gastroenterology.

[28]  Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes. , 1996, Endocrinology.

[29]  C. Woolf,et al.  Can we conquer pain? , 2002, Nature Neuroscience.

[30]  A. Malmberg,et al.  Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat , 1994, Neuroscience Letters.

[31]  C. Woolf,et al.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.

[32]  G. Stoll,et al.  The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling , 2004, Journal of Neuroimmunology.

[33]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[34]  Steven F. Maier,et al.  Glial activation: a driving force for pathological pain , 2001, Trends in Neurosciences.

[35]  W. Ma,et al.  Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury , 2003, Neuroscience.

[36]  D. Tracey,et al.  Hyperalgesia due to nerve injury: role of prostaglandins , 1999, Neuroscience.

[37]  P. Anand,et al.  Cyclooxygenase‐2 (Cox‐2) in injured human nerve and a rat model of nerve injury , 2004, Journal of the peripheral nervous system : JPNS.

[38]  Lingzhi Fan,et al.  The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system , 1988, Neuroscience Letters.

[39]  W. Hickey,et al.  Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat , 1997, Journal of Neuroimmunology.

[40]  M. Breckwoldt,et al.  PGE2 and PGF2 alpha release by human peritoneal macrophages in endometriosis. , 1996, Prostaglandins.

[41]  R. Breyer,et al.  Prostanoid receptors: subtypes and signaling. , 2001, Annual review of pharmacology and toxicology.

[42]  C. Woolf,et al.  Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain , 2004, Neuroscience.

[43]  A. Malmberg,et al.  Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. , 1992, The Journal of pharmacology and experimental therapeutics.

[44]  C. Woolf,et al.  Transcriptional and posttranslational plasticity and the generation of inflammatory pain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. FitzGerald,et al.  Genetic and pharmacological analysis of prostanoid receptor function. , 2001, The Journal of clinical investigation.

[46]  H. Hirai,et al.  Characterization of the mouse prostaglandin F receptor gene: a transgenic mouse study of a regulatory region that controls its expression in the stomach and kidney but not in the ovary , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[47]  J. Eisenach,et al.  Four PGE2 EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation , 2003, Experimental Neurology.

[48]  K. Omote,et al.  The Effects of Intrathecal Administration of an Antagonist for Prostaglandin E Receptor Subtype EP1 on Mechanical and Thermal Hyperalgesia in a Rat Model of Postoperative Pain , 2002, Anesthesia and analgesia.

[49]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[50]  G. Kreutzberg.  Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[51]  A. Sakamoto,et al.  A Prostaglandin E2 Receptor Subtype EP1 Receptor Antagonist (ONO-8711) Reduces Hyperalgesia, Allodynia, and C-fos Gene Expression in Rats with Chronic Nerve Constriction , 2001, Anesthesia and analgesia.

[52]  J. Eisenach,et al.  Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain , 2002, The European journal of neuroscience.

[53]  T. Yaksh,et al.  Spinal synthesis and release of prostanoids after peripheral injury and inflammation. , 1999, Advances in experimental medicine and biology.

[54]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[55]  K. Bley,et al.  The role of IP prostanoid receptors in inflammatory pain. , 1998, Trends in pharmacological sciences.

[56]  P. Gebicke-haerter,et al.  Expression and regulation of cyclooxygenase-2 in rat microglia. , 1997, European journal of biochemistry.

[57]  G. Levi,et al.  Down‐regulation of microglial cyclo‐oxygenase‐2 and inducible nitric oxide synthase expression by lipocortin 1 , 1999, British journal of pharmacology.

[58]  J. Eisenach,et al.  Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury , 2002, Brain Research.

[59]  A. Ford,et al.  ATP‐gated ion channel P2X3 is increased in human inflammatory bowel disease , 2001, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[60]  H. Jacobson,et al.  Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. , 1994, The Journal of clinical investigation.

[61]  J. McGee,et al.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages. , 1988, Journal of clinical pathology.

[62]  A. Ford-hutchinson,et al.  Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues , 1993, FEBS letters.

[63]  R. Coggeshall,et al.  Reorganization of central terminals of myelinated primary afferents in the rat dorsal horn following peripheral axotomy , 1995, The Journal of comparative neurology.